[Coma due to an overdose of valnoctamide]. 1992

C F Melissant, and A A Vinks, and H P Sleeboom
Ziekenhuis Leyenburg, afd. Interne Geneeskunde, 's-Gravenhage.

We report a 27-year-old man, who became comatose after autopoisoning with a high dose of valnoctamide. He was mechanically ventilated for 12 hours and survived without serious side effects. Valnoctamide blood levels were monitored in order to study the pharmacokinetics of oral overdosing of this drug. Serum half-time levels appeared to be approximately 15 hours.

UI MeSH Term Description Entries
D008297 Male Males
D003128 Coma A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION. Comatose,Pseudocoma,Comas,Pseudocomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D013406 Suicide, Attempted The unsuccessful attempt to kill oneself. Parasuicide,Suicide Attempt,Attempt, Suicide,Attempted Suicide,Parasuicides
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents

Related Publications

C F Melissant, and A A Vinks, and H P Sleeboom
June 1992, Nederlands tijdschrift voor geneeskunde,
C F Melissant, and A A Vinks, and H P Sleeboom
January 1979, Clinical pharmacology and therapeutics,
C F Melissant, and A A Vinks, and H P Sleeboom
September 1979, Intensive care medicine,
C F Melissant, and A A Vinks, and H P Sleeboom
September 1968, Southern medical journal,
C F Melissant, and A A Vinks, and H P Sleeboom
February 1966, Lancet (London, England),
C F Melissant, and A A Vinks, and H P Sleeboom
May 1980, Psychophysiology,
C F Melissant, and A A Vinks, and H P Sleeboom
July 1979, Archives of toxicology,
C F Melissant, and A A Vinks, and H P Sleeboom
March 2022, Journal of medical case reports,
C F Melissant, and A A Vinks, and H P Sleeboom
April 1989, Journal of neurology, neurosurgery, and psychiatry,
C F Melissant, and A A Vinks, and H P Sleeboom
January 2006, Revista de neurologia,
Copied contents to your clipboard!